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BACKGROUND: Endoscopic submucosal dissection is a new Japanese technique characterized by en-bloc resection of the entire 
lesion irrespective of size, with lower local recurrence when compared to endoscopic mucosal resection.
OBJECTIVE: To evaluate the feasibility, early results and complications of the endoscopic submucosal dissection technique for 
treating early gastric and esophageal cancer at the Endoscopic Unit of Clinics Hospital and Cancer Institute of the São Paulo University.
MATERIALS AND METHODS: Twenty patients underwent endoscopic resection using the endoscopic submucosal dissection 
technique for early gastric or esophageal cancer. The patients were evaluated prospectively as to the executability of the technique, 
the short-term results of the procedure and complications. 
RESULTS: Sixteen gastric adenocarcinoma lesions and six esophageal squamous carcinoma lesions were resected. In the stomach, 
the mean diameter of the lesions was 16.2 mm (0.6-3.5 mm). Eight lesions were type IIa + IIc, four were type IIa and four IIc, 
with thirteen being well differentiated and three undifferentiated. Regarding the degree of invasion, five were M2, seven were M3, 
two were Sm1 and one was Sm2. The mean duration of the procedures was 85 min (20-160 min). In the esophagus, all of the le-
sions were type IIb, with a mean diameter of 17.8 mm (6-30 mm). Regarding the degree of invasion, three were M1, one was M2, 
one was M3 and one was Sm1. All had free lateral and deep margins. The mean time of the procedure was 78 min (20-150 min). 
CONCLUSION: The endoscopic submucosal dissection technique was feasible in our service with a high success rate. 
KEYWORDS: Endoscopic mucosal; resection; endoscopic submucosal dissection; early gastric cancer; early esophageal cancer; 
endoscopy.
INTRODUCTION
Upper gastrointestinal (GI) endoscopy has been valuable 
for the diagnosis, staging and treatment of early-stage GI 
neoplasias. Lesions confined to the mucosa throughout the 
GI tract are susceptible to endoscopic resection, allowing for 
minimally invasive and curative treatment. 
The resection of neoplastic tissue through endoscopic 
techniques, known as endoscopic mucosal resection (EMR), 
allows for histological analysis of the resected specimen, 
thereby allowing diagnostic confirmation and determination 
of the degree of invasion depth into the wall of the organ. 
This is relevant for determining whether the endoscopic 
resection was curative. 
Currently, there are several EMR methods that may 
be divided according to the technique of mucosal capture 
into: traction (strip-biopsy or lift-and-cut); suction (cap 
and elastic band ligation); and compression (monofilament 
snare). 
Endoscopic submucosal resection (ESD) is a new 
Japanese technique that involves en-bloc resection of the 
entire lesion irrespective of size, allowing for a detailed 
analysis of the resected margins and depth of invasion 
and producing a lower local recurrence when compared 
to EMR techniques (1). Most of the relevant series on 378
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ESD describe the experience of eastern centers, where it 
is already incorporated into routine practice. Based on the 
eastern experience, it is clear that ESD is a complex and 
time-consuming technique, which are factors that might 
hinder the diffusion of this new modality of endoscopic 
treatment.
The aim of this study is to report the feasibility of ESD in 
our institution, specifically addressing the initial results and 
the technique employed.
PATIENTS AND METHODS
Between March 2007 and January 2009, 20 patients with 
early stage gastric or esophageal cancer were prospectively 
included in the present study. They were treated by two 
senior physicians using the ESD technique, which was 
performed in the Gastrointestinal Endoscopy Unit of the 
Clinics Hospital and the Cancer Institute of the São Paulo 
University. The procedures were performed with the consent 
of the patients after they were informed of the risks and 
benefits of the method.
Before the procedure was developed, all of the diagnoses 
were done through endoscopic biopsies, and staging was 
done by echo-endoscopy with a 12 MHz miniprobe, except 
in cases in which endoscopy was highly suggestive of an 
early lesion. 
Using a standard video endoscope (Olympus GIF−Q140 
or GIF−Q160; Olympus, Tokyo, Japan) with 2% Lugol’s 
solution for the esophagus and 0.4% Indigocarmin for the 
stomach, the lesions were classified as Japanese endoscopic 
superficial cancer, and we observed the location and 
superficial extent of the lesions. 
The indication and cure criteria adopted for ESD in the 
stomach were the same as those published by Godota et al.1 
(Table1).
The indications and cure criteria for ESD in the 
esophagus have also been previously described (2, 3, 4) (Table 
2).
Technical method of ESD employed
The ESD was done using a needle knife with a ceramic 
ball in its tip, known as an insulation-tipped diathermic knife 
(IT-knife, Olympus Inc. São Paulo, Brazil).
The technique employed had the following basic stages: 
marking of the periphery of the lesion with a conventional 
needle knife set at 20 W coagulation mode (ICC200, Erbe, 
Tubingen, Germany); injection of 250 ml of saline solution 
or Manitol (10%) + 1 ml of epinephrine (1:1000) + 2 mL of 
0.5% indigo carmine dye into the submucosa; generation of 
small incisions in the mucosa at the periphery of the lesion at 
four cardinal points with the conventional needle knife set at 
80 W endocut mode with effect 3 (ICC200, Erbe, Tubingen, 
Germany); circumferential mucosal cutting with the IT knife 
gathering the four openings performed with the needle knife; 
and submucosal dissection of the entire lesion with the IT 
knife (re 1).
Prophylactic antibiotic IV was administered in all 
patients.
The time of the procedure was recorded in all cases 
from the point of marking the periphery of the lesion to the 
complete resection of the lesion.
Post EDS histological analyses 
The resected specimens were retrieved, stretched and 
Table 1 - Indication criteria adopted for gastric cancer endoscopic submucosal resection.
INTRAMUCOSAL CANCER SUBMUCOSAL CANCER
Differentiated adenocarcinoma  - Superficial submucosal invasion, < 500 µm (Sm1)
- No lymphatic-vascular invasion - Differentiated adenocarcinoma
- Irrespective of tumor size without ulcer findings - No lymphatic-vascular invasion
- Tumor less than 3 cm in size with ulcer findings - Tumor less than 3 cm in size
Undifferentiated adenocarcinoma
- No lymphatic-vascular invasion
- No ulcer findings
- Tumor less than 2 cm in size
Table 2 - Indication criteria adopted for esophageal cancer 
endoscopic submucosal resection
- Endoscopic signs of early lesions or echo-endoscopic examination con-
firming tumor limited to the mucosa or up to the superficial submucosa 
(Sm1). 
- Histological confirmation of squamous cell carcinoma or high−grade 
intraepithelial neoplasia restricted to the mucosa (M1 and M2).
- Lesions with M3 or Sm1 invasion without lymphatic and vascular 
involvement, no larger superficial size (< 2.5 mm).
- No signs of lymph node metastases. 379
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pinned onto a Styrofoam plate, and fixed in 10% formalin. 
Histological evaluation was performed using Japanese 
criteria, and the following points were analyzed: degree 
of differentiation, depth of invasion per the Japanese 
classification of early-stage cancer, and lateral margin 
involvement by the lesion. 
The resection was considered curative if it met the 
criteria of resection presented in Tables 1 and 2.
Follow-up
Double−dose proton pump inhibitor treatment was given 
after the procedure and continued for two months.
Only patients with small lesions (<1.5 cm) in the gastric 
antrum were discharged in the first 4 to 6 hr. The others 
remained in the hospital for 24 hr. 
Endoscopic control was done at 3, 6, 12 and 18 months 
after the procedure. In the absence of signs of residual 
or recurrent lesions after a period of 18 months, annual 
endoscopic control was indicated.
RESULTS
From the 20 patients included in the present study, 22 
lesions were resected, including 16 gastric adenocarcinomas 
and 6 esophageal squamous carcinomas (Figure 1). The 
clinicopathological characteristics of the cases are shown 
in Table 3.
From the 15 patients with gastric lesions, we resected 
16 lesions. No immediate or late complications, such as 
hemorrhage, perforation and stenosis, occurred in these 
cases. The only lesion with Sm2 invasion was referred for 
surgery. The two patients with Sm1 invasion did not present 
compromised margins; however, one patient had a focus of 
vascular invasion by the tumor. Clinical follow-up was opted 
for in this case, because the patient was diagnosed with 
sarcoma in the thigh with several pulmonary metastases. In 
the other patient with Sm1 invasion, surgery was indicated 
due to the undifferentiated nature of the lesion, and a 
residual lesion was not found in the surgical specimen. 
Three lesions were not removed in the monoblock: one 
located in the cardia measuring 15 mm, one in the posterior 
region of the antrum measuring 20 mm, and the other in the 
angular incisure measuring 35 mm in its greatest axis. 
Three lesions presented with compromised lateral 
margins. One lesion was complemented 30 days after ESD 
with EMR using the monofilament technique. The second 
was in a patient with an undifferentiated carcinoma with 
affected lateral and deep margins (Sm2); this patient was 
referred for surgical treatment after improvement of his 
Figure 1 - Endoscopic submucosal dissection of a gastric adenocarcinoma (IIa+IIc). A- Marking of the lesion. B- Circumferential cutting around the entire 
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clinical condition of common variable immunodeficiency, 
where a focus of residual carcinoma was confirmed. For 
the third case with affected lateral margins, an endoscopic 
control was done 30 days after ESD. Several biopsy 
specimens were obtained from the resected border and 
determined to have no residual focus of carcinoma. Control 
follow-up was performed 90 days after resection, and the 
biopsies still did not have signs of residual lesion.
Excluding the two patients who underwent further 
surgery, the mean follow-up time was 9.5 months (2-24 
months), with one patient dying from pneumonia seven 
months following the resection. One patient developed 
a new gastric metachronous adenocarcinoma after one 
year of follow-up, which was also resected using the ESD 
technique. The lesion was located next to the pylorus, and 
the resection of this lesion involved almost two-thirds of the 
circumference of the pyloric canal without progressing to 
stenosis. 
From the five patients with esophageal squamous cell 
carcinoma, six lesions were removed. All patients were 
in treatment or follow-up of neck and head tumors. Two 
patients presented with pain and small pneumomediastinum; 
however, there was no evidence of perforation. Both cases 
had a good evolution with conservative treatment. Other 
complications, like bleeding and stenosis, did not happen. 
All had free lateral and deep margins. In four patients, 
the mean follow-up time was nine months (5-20 months) 
without residual or recurrent tumor. One patient was lost to 
follow-up. 
DISCUSSION
The presence of lymph node metastasis is closely related 
to the degree of invasion into the esophageal and gastric 
wall.
Esophageal lesions confined to M1 and M2 layers do 
not present lymph node metastasis. As the lesion becomes 
deeper, the incidence of metastasis is: M3 (9.1%), Sm1 
(15.4%), Sm2 (40.0%), and Sm3 (44.1%).5
According to the incidence of lymph node metastasis 
and local recurrence, Makuuchi5 defined the criteria 
for the endoscopic mucosal resection (EMR) of early 
esophageal lesions in 1996. The evolution of endoscopic 
resection methods has expanded the range of indications for 
endoscopic resections, but such procedures are formally not 
indicated in cases with Sm2 and Sm3 invasion detected on 
endoscopic ultrasound. 
In the stomach, the incidence of lymph node metastasis 
for lesions confined to the mucosa and submucosa is 
generally considered to range from 0% to 3% and 9% to 
19%, respectively 6.
An analysis of 1,312 gastrectomies for gastric cancer7 
demonstrated a lymph node metastasis rate of 0.64% (3/462) 
for intestinal cancer confined to the mucosa, irrespective 
of the size of the lesion. The incidence of metastasis for 
undifferentiated lesions is rather high, even for lesions 
smaller in size.
In a study conducted at the National Cancer Center 
Hospital and the Cancer Institute Hospital in Tokyo8 
on 3,016 intramucosal cancer lesions and 2,249 in the 
submucosa, the incidence of lymph node metastases 
was 2.2% for intramucosal cancers and 17.9% for the 
submucosal cancers. For the well-differentiated intramucosal 
cancers, none of the 929 lesions without ulceration were 
associated with nodal metastases regardless of the size of 
the lesion. Depressed or ulcerated lesions larger than 30 
mm and with invasion into the lymphatic system or venules 
were associated with metastases. The overall risk of LN 
metastases in undifferentiated lesions was 4.2%. However, 
none of the 141 intramucosal undifferentiated lesions 
without ulceration less than 20 mm in size showed lymph 
node metastases. For submucosal invasive cancer, 145 






Mean age (range) 67.1 (32-81) 50.8 (48-55)
Male, n (%) 12 (80%) 4 (80%)
LOCATION, N
Antrum, body, cardia, angular 
incisure
8, 4, 3,1
Middle, distal part 4, 2
Lesion size, median (range), mm 16.2 (0.6 – 3.5) 17.8 (6-30)
MACROSCOPIC TYPE, N
IIa + IIc, IIa, IIc, IIb, IIa 8, 4, 4, 0, 0 0, 0, 0, 5, 1
Procedure times, median (range), 
min
85 (20-150) 78 (20-150)
En-block resection, n (%) 13 (81.2%) 5 (83.3%)
DEPTH OF INVASION
M1, M2, M3, Sm1, Sm2 0, 5, 8, 2, 1 3, 1, 1, 1, 0
Lateral margins compromised, n (%) 3 (18.7%) 0











Immediate bleeding, later bleeding, 
stenosis 
0, 0, 0 0, 0, 0
Perforations, pneumomediastinum 0, 0 0, 2
Mortality  0 0381
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lesions smaller than 30 mm that were well-differentiated, 
lacked lymphovascular invasion, and had submucosal 
penetration < 500 µm (Sm1) were free of lymph node 
metastasis.
The technique of submucosal dissection using the 
IT-knife was the first technique of endoscopic mucosal 
dissection used in the National Cancer Center Hospital, 
Japan.9,10 Other ESD techniques were subsequently 
developed using different types of accessories, such as the 
hook-knife, the flex-knife, the triangle-tipped knife, and, 
more recently, the flush-knife and dual-knife.
In contrast to EMR techniques, ESD allows for large en-
bloc resections, contributing to better evaluation of resected 
specimens and consequently lower local recurrence of the 
neoplasia. In a previous series from our group, endoscopic 
mucosal resection (EMR) of gastric cancer in more than 
two fragments (piecemeal resection) was a risk factor for 
incomplete resection (OR=7.34)11. The incidence of local 
recurrence after EMR procedures ranges from 2.3% to 
36.5%, whereas for ESD it ranged from 0% to 2% in initial 
studies 1. For en-bloc resection of gastric neoplasias, success 
rates for both techniques are similar and over 90% for 
lesions smaller than 1 cm in diameter. For lesions larger than 
1 cm, endoscopic submucosal dissection has a success rate 
of over 90%, but for mucosectomies, this rate is decreased 
by half.12
The  ESD  procedure  duration  and  incidence  of 
complications are directly related to the experience of the 
endoscopist with this method. 
The lesion that presented the most technical difficulty 
in this study was located in the cardia, where the procedure 
lasted 2 hours and 30 min. Another difficult lesion was 
located in the angular incisure, where the procedure lasted 
2 hours and 40 min, with a lesion extension of 3.5 cm. The 
lesions that presented the least technical difficulty were 
located in the antrum, particularly in the anterior distal 
region, where the procedure lasted only 20 min. 
The perforation incidence with different EMR techniques 
ranged from 0% to 4.0%, whereas with ESD it ranged from 
0% to 5.0%. When comparing these methods, Watanabe 
and colleagues12 did not identify a statistical difference in 
the incidence of perforation, which was 3.2% for EMR and 
4.2% for ESD.12 However, Oka and colleagues23 analyzed 
only non-ulcerative lesions and found a 0.5% incidence 
for EMR and a 9.7% incidence for EDS with statistical 
difference. Oda et al.13, in a multicenter retrospective study 
of early gastric cancer, observed the incidence of perforation 
with ESD (3.6%; 11/303) to be significantly higher than that 
with EMR (1.2%; 5/411).
Bleeding is the most frequent complication for 
techniques of endoscopic resection. Its incidence for EMR 
was found to reach 8%, whereas for ESD it reached 7%. 
Oka and colleagues14 found that the incidence of bleeding 
during and after EMR was 7.6% and 3.9%, respectively, for 
non-ulcerative lesions, whereas this incidence during and 
after ESD was 22.6% and 6.2%, respectively. In a study by 
Oda13 et al., only one patient submitted to EMR required 
blood transfusion; no patients in the ESD group required 
transfusion.
Both perforation and bleeding are endoscopically treated 
with great success.
In the present study, there were no cases of perforation 
or other significant complications. 
Given the present results and the data in the literature, 
we conclude that the ESD technique is feasible in our 
environment. 
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